Literature DB >> 16126559

Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?

Auni M Juutilainen1, Erkki T Voutilainen, Leena Mykkänen, Leo Niskanen.   

Abstract

Volume loading is considered the golden standard of the confirmatory tests in the diagnostics of primary aldosteronism (PA). However, it is time-consuming, and it is unclear to what extent it improves the diagnostics of PA in comparison to simple screening tests. To study this question, the diagnostics with and without oral sodium loading (OSL) were evaluated by receiver operating characteristic curves analyses in 77 consecutive OSL patients. The final diagnosis was essential hypertension in 39 cases and PA in 38 cases, determined by review of the patient records, biochemical tests, imaging findings, and the response to therapy with spironolactone and/or operation. Plasma aldosterone-to-renin-activity ratio (ARR) and daily urinary aldosterone had a good diagnostic ability that did not significantly improve by accomplishing OSL. Cut-off values with optimal sensitivity and specificity were >or=1050 pmol/l per ng/ml/h for upright ARR, and >or=45 nmol/day for daily urinary aldosterone. To conclude, carefully conducted outpatient tests are sufficient for the diagnostics of PA, when the diagnosis is justified by the positive response to treatment. However, volume loading serves as an additional diagnostic tool in the most problematic cases, improving slightly the discriminative ability of urinary aldosterone determination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126559     DOI: 10.1080/08037050510034329

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  2 in total

1.  Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.

Authors:  Alexander A Leung; Christopher J Symonds; Gregory L Hundemer; Paul E Ronksley; Diane L Lorenzetti; Janice L Pasieka; Adrian Harvey; Gregory A Kline
Journal:  Hypertension       Date:  2022-06-02       Impact factor: 9.897

2.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.